《港股开市》港股高开21点 友邦再升穿90元 小米上试30元
市场憧憬美国国会通过新刺激经济方案，美股三大指数上升，道指升337点或1.1%，纳指创新高。港股今早跟随高开。恒指高开213点或0.8%，报26,421点；国指高开76点或0.7%，报10,476点；恒生科技指数高开64点或0.8%，报8,158点。
科技股方面，腾讯(00700.HK)高开0.6%报563.5元，阿里巴巴(09988.HK)高开1.1%报248.8元，小米(01810.HK)高开1.4%报29.95元，美团(03690.HK)低开0.1%报274元，京东(09618.HK)高开0.8%，网易(09999.HK)低开1.4%。京东健康(06618.HK)及金蝶(00268.HK)各高开2.8%及2.1%。
手机股方面，丘钛(01478.HK)考虑分拆昆山丘钛A股上市，股价升7.5%，瑞声(02018.HK)及舜宇(02382.HK)各升1.3%及1.7%。晶片股华虹半导体(01347.HK)高开2.4%。中芯国际(00981.HK)开市前停牌，早前委任蒋尚义为副董事长，而报道指首席执行官梁孟松向董事会递交书面辞呈。中移动(00941.HK)高开1.1%报44.65元，中电信(00728.HK)及中国铁塔(00788.HK)各高开2.3%及1.7%。
金融股方面，汇控(00005.HK)高开1.5%报41.6元，港交所(00388.HK)高开0.9%报386元，友邦(01299.HK)高开0.6%报90.2元，内银股建行(00939.HK)、工行(01398.HK)及中行(03988.HK)各高开0.8%至1.1%。
其他股份方面，万洲(00288.HK)高开1.9%，吉利(00175.HK)及比亚迪(01211.HK)各高开2.2%及2.1%，翰森制药(03692.HK)及国药(01099.HK)各高开2.8%及2.3%，石药(01093.HK)及药明生物(02269.HK)各高开1.2%。内房股龙湖(00960.HK)及地产股恒隆地产(00101.HK)各高开2.2%及2.9%。
蓝月亮(06993.HK)开市报15.32元，较上市价13.16元高开16.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
